Plexxikon selects Clinipace to manage trials

Friday, March 18, 2011 10:51 AM

Plexxikon, a company focused on the discovery and development of novel small molecule pharmaceuticals to treat human disease, has selected Clinipace Worldwide, a digital CRO, to manage all aspects of four clinical trials comprising a phase I healthy volunteer study, a phase Ib rheumatoid arthritis (RA) study and two phase II oncology studies. 
  
“We chose Clinipace Worldwide to manage these important clinical trials based on Clinipace’s commitment to customer service,” said Paul Lin, MD, MBA, director of business development at Plexxikon. “Plexxikon’s programs are highly differentiated from its competition, and we needed a highly differentiated CRO to get the job done.”


“As a digital CRO, we know that successful trials hinge on the transparent exchange of trial and project data among all constituents,” said Jeff Williams, Clinipace CEO. “This platform enables our clients to substantially improve their ability to avoid problems and mitigate risk.”

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 15

Cancer Treatment Centers of America chooses WCG as its exclusive IRB, sheds five local hospital IRBs

Five southern research groups form public-private network to help save time, money for clients with early-stage biologics

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs